Bermuda

Bermuda

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.52 (0.44 - 0.62) 2019 Modelled IHME
0.52 (0.44 - 0.61) 2018 Modelled IHME
0.52 (0.44 - 0.60) 2017 Modelled IHME
0.52 (0.45 - 0.60) 2016 Modelled IHME
0.53 (0.45 - 0.61) 2015 Modelled IHME
0.53 (0.45 - 0.61) 2014 Modelled IHME
0.53 (0.45 - 0.61) 2013 Modelled IHME
0.53 (0.45 - 0.61) 2012 Modelled IHME
0.53 (0.45 - 0.61) 2011 Modelled IHME
0.53 (0.45 - 0.61) 2010 Modelled IHME
0.54 (0.46 - 0.62) 2009 Modelled IHME
0.54 (0.46 - 0.63) 2008 Modelled IHME
0.55 (0.46 - 0.64) 2007 Modelled IHME
0.55 (0.47 - 0.64) 2006 Modelled IHME
0.55 (0.46 - 0.65) 2005 Modelled IHME
0.55 (0.47 - 0.65) 2004 Modelled IHME
0.55 (0.46 - 0.64) 2003 Modelled IHME
0.55 (0.46 - 0.65) 2002 Modelled IHME
0.55 (0.46 - 0.65) 2001 Modelled IHME
0.55 (0.45 - 0.65) 2000 Modelled IHME
0.55 (0.46 - 0.65) 1999 Modelled IHME
0.56 (0.46 - 0.65) 1998 Modelled IHME
0.56 (0.47 - 0.65) 1997 Modelled IHME
0.56 (0.47 - 0.65) 1996 Modelled IHME
0.56 (0.47 - 0.65) 1995 Modelled IHME
0.56 (0.47 - 0.65) 1994 Modelled IHME
0.56 (0.47 - 0.65) 1993 Modelled IHME
0.56 (0.47 - 0.65) 1992 Modelled IHME
0.56 (0.47 - 0.65) 1991 Modelled IHME
0.56 (0.47 - 0.66) 1990 Modelled IHME
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.24 (0.16 - 0.32) 2019 Modelled IHME
0.23 (0.16 - 0.31) 2018 Modelled IHME
0.23 (0.17 - 0.31) 2017 Modelled IHME
0.24 (0.17 - 0.32) 2016 Modelled IHME
0.24 (0.17 - 0.33) 2015 Modelled IHME
0.25 (0.17 - 0.33) 2014 Modelled IHME
0.25 (0.17 - 0.33) 2013 Modelled IHME
0.25 (0.17 - 0.33) 2012 Modelled IHME
0.25 (0.17 - 0.33) 2011 Modelled IHME
0.25 (0.17 - 0.33) 2010 Modelled IHME
0.25 (0.18 - 0.33) 2009 Modelled IHME
0.25 (0.18 - 0.34) 2008 Modelled IHME
0.26 (0.18 - 0.34) 2007 Modelled IHME
0.26 (0.18 - 0.35) 2006 Modelled IHME
0.27 (0.18 - 0.36) 2005 Modelled IHME
0.27 (0.18 - 0.35) 2004 Modelled IHME
0.27 (0.18 - 0.35) 2003 Modelled IHME
0.27 (0.18 - 0.35) 2002 Modelled IHME
0.26 (0.18 - 0.35) 2001 Modelled IHME
0.26 (0.18 - 0.36) 2000 Modelled IHME
0.27 (0.18 - 0.36) 1999 Modelled IHME
0.27 (0.19 - 0.36) 1998 Modelled IHME
0.27 (0.19 - 0.36) 1997 Modelled IHME
0.27 (0.19 - 0.37) 1996 Modelled IHME
0.27 (0.19 - 0.37) 1995 Modelled IHME
0.27 (0.19 - 0.37) 1994 Modelled IHME
0.27 (0.19 - 0.37) 1993 Modelled IHME
0.27 (0.19 - 0.37) 1992 Modelled IHME
0.27 (0.19 - 0.37) 1991 Modelled IHME
0.27 (0.19 - 0.37) 1990 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.36 (1.76 - 3.13) 2019 Modelled IHME
2.33 (1.74 - 3.07) 2018 Modelled IHME
2.29 (1.70 - 3) 2017 Modelled IHME
2.26 (1.70 - 2.95) 2016 Modelled IHME
2.2 (1.67 - 2.84) 2015 Modelled IHME
2.14 (1.64 - 2.76) 2014 Modelled IHME
2.07 (1.61 - 2.65) 2013 Modelled IHME
2.02 (1.57 - 2.58) 2012 Modelled IHME
1.97 (1.54 - 2.54) 2011 Modelled IHME
1.97 (1.52 - 2.54) 2010 Modelled IHME
1.93 (1.50 - 2.49) 2009 Modelled IHME
1.91 (1.48 - 2.47) 2008 Modelled IHME
1.88 (1.46 - 2.43) 2007 Modelled IHME
1.88 (1.47 - 2.46) 2006 Modelled IHME
1.87 (1.46 - 2.42) 2005 Modelled IHME
1.86 (1.45 - 2.42) 2004 Modelled IHME
1.88 (1.45 - 2.43) 2003 Modelled IHME
1.89 (1.47 - 2.42) 2002 Modelled IHME
1.92 (1.48 - 2.46) 2001 Modelled IHME
2.01 (1.54 - 2.59) 2000 Modelled IHME
2.15 (1.66 - 2.74) 1999 Modelled IHME
2.29 (1.78 - 2.91) 1998 Modelled IHME
2.5 (1.95 - 3.14) 1997 Modelled IHME
2.84 (2.21 - 3.57) 1996 Modelled IHME
3.04 (2.37 - 3.79) 1995 Modelled IHME
3.29 (2.55 - 4.10) 1994 Modelled IHME
3.48 (2.72 - 4.35) 1993 Modelled IHME
3.57 (2.79 - 4.44) 1992 Modelled IHME
3.77 (2.95 - 4.72) 1991 Modelled IHME
3.84 (3.01 - 4.82) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
2 (1 - 2) 2019 Modelled IHME
2 (1 - 2) 2018 Modelled IHME
1 (1 - 2) 2017 Modelled IHME
1 (1 - 2) 2016 Modelled IHME
1 (1 - 2) 2015 Modelled IHME
1 (1 - 2) 2014 Modelled IHME
1 (1 - 2) 2013 Modelled IHME
1 (1 - 2) 2012 Modelled IHME
1 (1 - 2) 2011 Modelled IHME
1 (1 - 2) 2010 Modelled IHME
1 (1 - 2) 2009 Modelled IHME
1 (1 - 2) 2008 Modelled IHME
1 (1 - 2) 2007 Modelled IHME
1 (1 - 2) 2006 Modelled IHME
1 (1 - 2) 2005 Modelled IHME
1 (1 - 2) 2004 Modelled IHME
1 (1 - 2) 2003 Modelled IHME
1 (1 - 2) 2002 Modelled IHME
1 (1 - 2) 2001 Modelled IHME
1 (1 - 2) 2000 Modelled IHME
1 (1 - 2) 1999 Modelled IHME
1 (1 - 2) 1998 Modelled IHME
2 (1 - 2) 1997 Modelled IHME
2 (1 - 2) 1996 Modelled IHME
2 (1 - 2) 1995 Modelled IHME
2 (2 - 3) 1994 Modelled IHME
2 (2 - 3) 1993 Modelled IHME
2 (2 - 3) 1992 Modelled IHME
2 (2 - 3) 1991 Modelled IHME
2 (2 - 3) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
23 (16 - 31) 2019 Modelled IHME
23 (16 - 31) 2018 Modelled IHME
23 (16 - 31) 2017 Modelled IHME
23 (17 - 32) 2016 Modelled IHME
23 (17 - 32) 2015 Modelled IHME
23 (17 - 32) 2014 Modelled IHME
24 (17 - 32) 2013 Modelled IHME
24 (17 - 32) 2012 Modelled IHME
24 (17 - 33) 2011 Modelled IHME
24 (17 - 33) 2010 Modelled IHME
24 (17 - 33) 2009 Modelled IHME
24 (17 - 33) 2008 Modelled IHME
24 (17 - 33) 2007 Modelled IHME
24 (17 - 32) 2006 Modelled IHME
24 (17 - 32) 2005 Modelled IHME
24 (17 - 32) 2004 Modelled IHME
24 (17 - 32) 2003 Modelled IHME
23 (17 - 32) 2002 Modelled IHME
23 (17 - 32) 2001 Modelled IHME
23 (17 - 32) 2000 Modelled IHME
24 (17 - 32) 1999 Modelled IHME
24 (17 - 32) 1998 Modelled IHME
24 (17 - 32) 1997 Modelled IHME
24 (17 - 32) 1996 Modelled IHME
24 (18 - 32) 1995 Modelled IHME
24 (18 - 32) 1994 Modelled IHME
24 (18 - 33) 1993 Modelled IHME
24 (18 - 33) 1992 Modelled IHME
24 (18 - 33) 1991 Modelled IHME
24 (18 - 33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.65 (1.33 - 2.06) 2019 Modelled IHME
1.64 (1.34 - 2.04) 2018 Modelled IHME
1.62 (1.33 - 2.02) 2017 Modelled IHME
1.59 (1.32 - 1.96) 2016 Modelled IHME
1.56 (1.29 - 1.92) 2015 Modelled IHME
1.57 (1.29 - 1.93) 2014 Modelled IHME
1.57 (1.29 - 1.93) 2013 Modelled IHME
1.57 (1.29 - 1.94) 2012 Modelled IHME
1.58 (1.29 - 1.96) 2011 Modelled IHME
1.58 (1.29 - 1.97) 2010 Modelled IHME
1.59 (1.29 - 1.97) 2009 Modelled IHME
1.59 (1.30 - 1.96) 2008 Modelled IHME
1.6 (1.30 - 1.97) 2007 Modelled IHME
1.61 (1.31 - 1.98) 2006 Modelled IHME
1.62 (1.32 - 1.99) 2005 Modelled IHME
1.64 (1.34 - 2) 2004 Modelled IHME
1.65 (1.35 - 2.03) 2003 Modelled IHME
1.67 (1.36 - 2.07) 2002 Modelled IHME
1.69 (1.37 - 2.10) 2001 Modelled IHME
1.71 (1.38 - 2.10) 2000 Modelled IHME
1.73 (1.40 - 2.13) 1999 Modelled IHME
1.74 (1.41 - 2.16) 1998 Modelled IHME
1.76 (1.42 - 2.18) 1997 Modelled IHME
1.78 (1.44 - 2.20) 1996 Modelled IHME
1.79 (1.45 - 2.21) 1995 Modelled IHME
1.8 (1.46 - 2.23) 1994 Modelled IHME
1.81 (1.47 - 2.25) 1993 Modelled IHME
1.82 (1.47 - 2.26) 1992 Modelled IHME
1.82 (1.48 - 2.28) 1991 Modelled IHME
1.83 (1.48 - 2.29) 1990 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.94 (2.13 - 3.96) 2019 Modelled IHME
2.88 (2.10 - 3.82) 2018 Modelled IHME
2.83 (2.07 - 3.75) 2017 Modelled IHME
2.78 (2.06 - 3.68) 2016 Modelled IHME
2.7 (2.02 - 3.57) 2015 Modelled IHME
2.62 (1.98 - 3.44) 2014 Modelled IHME
2.53 (1.95 - 3.33) 2013 Modelled IHME
2.46 (1.89 - 3.25) 2012 Modelled IHME
2.41 (1.86 - 3.18) 2011 Modelled IHME
2.41 (1.86 - 3.19) 2010 Modelled IHME
2.38 (1.84 - 3.12) 2009 Modelled IHME
2.37 (1.82 - 3.09) 2008 Modelled IHME
2.34 (1.80 - 3.07) 2007 Modelled IHME
2.34 (1.80 - 3.08) 2006 Modelled IHME
2.34 (1.80 - 3.05) 2005 Modelled IHME
2.35 (1.81 - 3.05) 2004 Modelled IHME
2.38 (1.84 - 3.10) 2003 Modelled IHME
2.43 (1.88 - 3.16) 2002 Modelled IHME
2.46 (1.90 - 3.20) 2001 Modelled IHME
2.59 (2.01 - 3.36) 2000 Modelled IHME
2.74 (2.15 - 3.55) 1999 Modelled IHME
2.91 (2.27 - 3.73) 1998 Modelled IHME
3.13 (2.43 - 4.01) 1997 Modelled IHME
3.5 (2.71 - 4.45) 1996 Modelled IHME
3.69 (2.88 - 4.66) 1995 Modelled IHME
3.97 (3.08 - 5.03) 1994 Modelled IHME
4.16 (3.23 - 5.28) 1993 Modelled IHME
4.23 (3.30 - 5.37) 1992 Modelled IHME
4.44 (3.47 - 5.62) 1991 Modelled IHME
4.54 (3.55 - 5.72) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
2 (1 - 3) 2019 Modelled IHME
2 (1 - 2) 2018 Modelled IHME
2 (1 - 2) 2017 Modelled IHME
2 (1 - 2) 2016 Modelled IHME
2 (1 - 2) 2015 Modelled IHME
2 (1 - 2) 2014 Modelled IHME
2 (1 - 2) 2013 Modelled IHME
2 (1 - 2) 2012 Modelled IHME
2 (1 - 2) 2011 Modelled IHME
2 (1 - 2) 2010 Modelled IHME
2 (1 - 2) 2009 Modelled IHME
2 (1 - 2) 2008 Modelled IHME
2 (1 - 2) 2007 Modelled IHME
2 (1 - 2) 2006 Modelled IHME
2 (1 - 2) 2005 Modelled IHME
2 (1 - 2) 2004 Modelled IHME
2 (1 - 2) 2003 Modelled IHME
2 (1 - 2) 2002 Modelled IHME
2 (1 - 2) 2001 Modelled IHME
2 (1 - 2) 2000 Modelled IHME
2 (1 - 2) 1999 Modelled IHME
2 (1 - 2) 1998 Modelled IHME
2 (2 - 2) 1997 Modelled IHME
2 (2 - 3) 1996 Modelled IHME
2 (2 - 3) 1995 Modelled IHME
2 (2 - 3) 1994 Modelled IHME
3 (2 - 3) 1993 Modelled IHME
3 (2 - 3) 1992 Modelled IHME
3 (2 - 3) 1991 Modelled IHME
3 (2 - 3) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
23 (16 - 31) 2019 Modelled IHME
23 (16 - 30) 2018 Modelled IHME
23 (16 - 30) 2017 Modelled IHME
23 (16 - 30) 2016 Modelled IHME
23 (16 - 30) 2015 Modelled IHME
23 (16 - 30) 2014 Modelled IHME
22 (16 - 30) 2013 Modelled IHME
23 (16 - 30) 2012 Modelled IHME
23 (16 - 30) 2011 Modelled IHME
22 (16 - 30) 2010 Modelled IHME
23 (16 - 30) 2009 Modelled IHME
22 (16 - 30) 2008 Modelled IHME
22 (16 - 30) 2007 Modelled IHME
22 (16 - 29) 2006 Modelled IHME
22 (16 - 30) 2005 Modelled IHME
22 (16 - 30) 2004 Modelled IHME
23 (16 - 30) 2003 Modelled IHME
23 (16 - 30) 2002 Modelled IHME
23 (16 - 30) 2001 Modelled IHME
23 (16 - 30) 2000 Modelled IHME
23 (16 - 30) 1999 Modelled IHME
23 (16 - 30) 1998 Modelled IHME
23 (16 - 30) 1997 Modelled IHME
23 (16 - 31) 1996 Modelled IHME
23 (16 - 30) 1995 Modelled IHME
23 (16 - 30) 1994 Modelled IHME
22 (16 - 30) 1993 Modelled IHME
22 (15 - 30) 1992 Modelled IHME
22 (15 - 29) 1991 Modelled IHME
22 (15 - 30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.52 (%)
2019
(0.44 - 0.62(%))
IHME
HCV (RNA/cAg+)
1.65 (%)
2019
(1.33 - 2.06(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
2
2019
(1 - 2)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
2
2019
(1 - 3)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.24 (%)
2019, latest modelled
(0.16 - 0.32(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources